To compare the effectiveness of pap smear, via and colposcopy for screening of premalignant lesions of cervix

Cervical cancer poses a major public health challenge, particularly in developing nations, where around 80% of cases are diagnosed. Despite being preventable disease, it remains highly prevalent, with over 600,000 new and 340,000 deaths reported worldwide 2020. According to the GLOBOCAN 2020 data, cervical represented 9.4% all 18.3% India. However is now considered through screening curable, if detected early, which emphasizes importance "prevention better than cure". The current research utilized Pap smear, VIA, colposcopy identify abnormal appearances indicative carcinoma. : During span 18 months, study was carried out on 329 women who were attending OPD clinic at Integral Institute Of Medical Sciences Research hospital. With participants' consent, underwent smear tests as part study. In 61 (18.5%) found positive VIA findings 268 (81.5%) negative. this 85.7% smears normal, 18.5% positive, 77% pap 23 (37.5%) ASC (NOS/US), 8 (13.1%) AGC NOS, 6 (9.1%) AEC, 5 (8.2%) LSIL, HSIL negative normal (100%). colposcopies done, 73.6% 29 CIN I (47.5%), 10 III (16.3), II (9.8%) 13.2% cervicitis. Biopsy done patients, 49.2% I, 27% chronic cervicitis, 10% 3.2% squamous cell carcinoma 1.6% adenocarcinoma situ cx show no atypia. offers promising alternative cytology for detecting premalignant lesions uterine cervix, its cost-effectiveness, on-the-spot results, high sensitivity specificity. low-resource settings like India, substantial number lack access tests, especially well-suited. This method allows immediate counseling referral treatment, helping reduce delays diagnosis treatment can help minimize treatment.